A cheap gym supplement is turning up in cancer research: a new study says creatine helps immune cells fight tumors.
The paper, published today in iScience, a Cell Press journal, reports that increasing creatine uptake in immune cells enhances antitumor immunity - the body's natural ability to recognize and destroy cancerous cells. That's notable because creatine is best known for one job: helping muscle cells store and release energy fast. This research applies the same logic to immune cells, treating them as engines that perform better with more fuel in the tank. The result fits a growing pattern in cancer biology, sometimes called immunometabolism: immune cells that are otherwise capable of attacking tumors often underperform because they're starved for resources inside the tumor environment.
If boosting creatine uptake really does sharpen antitumor immunity, it points to a low-cost, well-understood molecule that could complement existing cancer treatments rather than replace them. That's a different mechanism than checkpoint inhibitors, the drug class that dominates modern immunotherapy by releasing the brakes on immune cells rather than feeding them. Cheap and already approved for other uses, creatine would be an unusually accessible starting point if the effect holds up.
Cancer research has a long history of promising metabolic tricks that work beautifully in a dish and quietly vanish before reaching a patient - creatine's turn in the spotlight is worth watching, not betting on.